Efficiency of a blended care version of an effective diabetes diet
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- NL-OMON29277
- Lead Sponsor
- Erasmus Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 200
•Type 2 Diabetes
•Age 18-75 years
•Obesity (BMI>30 kg/m2)
•Smartphone with Android or iOS
•Pregnancy or lactation during the trial
•Severe psychiatric problems, use of antipsychotic drugs
•Significant cardiac arrhythmias; unstable angina; decompensated congestive heart failure; carcinomas; major organ system failure; untreated hypothyroidism; end-stage renal disease;
•Myocardial infarction, cerebrovascular accident or major surgery during the previous 3 months.
•Corticosteroid induced diabetes (in patients still using corticosteroids)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main study endpoint is the difference in weight (kg) between the control and intervention group after 1 year, plus the difference between the total costs of the treatment in the control and intervention groups in euro’s.
- Secondary Outcome Measures
Name Time Method